207 related articles for article (PubMed ID: 29072981)
1. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
[TBL] [Abstract][Full Text] [Related]
2. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
4. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
Giess CS; Yeh ED; Raza S; Birdwell RL
Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
[TBL] [Abstract][Full Text] [Related]
5. Background parenchymal enhancement over exam time in patients with and without breast cancer.
Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
8. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
[TBL] [Abstract][Full Text] [Related]
10. Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI.
Sippo DA; Rutledge GM; Mercaldo SF; Burk KS; Edmonds CE; Dang PA; Lehman CD
Acad Radiol; 2020 May; 27(5):663-671. PubMed ID: 31327575
[TBL] [Abstract][Full Text] [Related]
11. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
[TBL] [Abstract][Full Text] [Related]
12. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
[TBL] [Abstract][Full Text] [Related]
13. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
15. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
[TBL] [Abstract][Full Text] [Related]
16. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
[TBL] [Abstract][Full Text] [Related]
17. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
[TBL] [Abstract][Full Text] [Related]
18. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.
Grimm LJ; Saha A; Ghate SV; Kim C; Soo MS; Yoon SC; Mazurowski MA
Acad Radiol; 2019 Jan; 26(1):69-75. PubMed ID: 29602724
[TBL] [Abstract][Full Text] [Related]
20. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]